SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-011833
Filing Date
2012-02-29
Accepted
2012-02-29 11:03:42
Documents
3
Period of Report
2012-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v304210_8k.htm 8-K 19004
2 EXHIBIT 99.1 v304210_ex99-1.htm EX-99.1 19978
3 GRAPHIC image_001.jpg GRAPHIC 2797
  Complete submission text file 0001144204-12-011833.txt   44363
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 12650616
SIC: 2834 Pharmaceutical Preparations